Table 4.

miRNAs in cholangiocarcinoma therapy resistance.

Drug	miRNA	Resistance	Target	Reference
Gemcitabine	miR-210	increase	HIF-3α	[141]
	miR-130a-3p	increase	PPARG	[142]
Cisplatin	miR-199a-3p	decrease	mTOR signaling pathway	[143]
5-fluorouracil	miR-106b	decrease	ZBTB7A	[144]